» Articles » PMID: 33677025

Biopolymer-liposome Hybrid Systems for Controlled Delivery of Bioactive Compounds: Recent Advances

Overview
Journal Biotechnol Adv
Date 2021 Mar 7
PMID 33677025
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Conventional liposomes still face many challenges associated with the poor physical and chemical stability, considerable loss of encapsulated cargo, lack of stimulus responsiveness, and rapid elimination from blood circulation. Integration of versatile functional biopolymers has emerged as an attractive strategy to overcome the limitation of usage of liposomes. This review comprehensively summarizes the most recent studies (2015-2020) and their challenges aiming at the exploration of biopolymer-liposome hybrid systems, including surface-modified liposomes, biopolymer-incorporated liposomes, guest-in-cyclodextrin-in-liposome, liposome-in-hydrogel, liposome-in-film, and liposome-in-nanofiber. The physicochemical principles and key technical information underlying the combined strategies for the fabrication of polymeric liposomes, the advantages and limitations of each of the systems, and the stabilization mechanisms are discussed through various case studies. Special emphasis is directed toward the synergistic efficiencies of biopolymers and phospholipid bilayers on encapsulation, protection, and controlled delivery of bioactives (e.g., vitamins, carotenoids, phenolics, peptides, and other health-related compounds) for the biomedical, pharmaceutical, cosmetic, and functional food applications. The major challenges, opportunities, and possible further developments for future studies are also highlighted.

Citing Articles

Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.

Tang L, Yang X, He L, Zhu C, Chen Q Lipids Health Dis. 2025; 24(1):31.

PMID: 39891269 PMC: 11783920. DOI: 10.1186/s12944-024-02429-x.


A state-of-the-art review of the recent advances of theranostic liposome hybrid nanoparticles in cancer treatment and diagnosis.

Azimizonuzi H, Ghayourvahdat A, Ahmed M, Kareem R, Jaber Zrzor A, Mansoor A Cancer Cell Int. 2025; 25(1):26.

PMID: 39871316 PMC: 11773959. DOI: 10.1186/s12935-024-03610-z.


Selection strategy for encapsulation of hydrophilic and hydrophobic ingredients with food-grade materials: A systematic review and analysis.

Huang R, Song H, Li S, Guan X Food Chem X. 2025; 25:102149.

PMID: 39867216 PMC: 11758843. DOI: 10.1016/j.fochx.2024.102149.


Sequential Release HydroLipo System for STING Gene Epigenetic Reprogramming and Immune Activation in Glioblastoma.

Yu H, Liu W, Ding K, Wu J, Wang C, Wang S Adv Sci (Weinh). 2024; 12(5):e2408323.

PMID: 39661716 PMC: 11792002. DOI: 10.1002/advs.202408323.


Optimizing Encapsulation of Active Compounds of Carrot By-Product in TPP-Chitosomes.

Malagutti E, Pinho S, Thomazini M, Tapia-Blacido D, Martelli Tosi M Foods. 2024; 13(16).

PMID: 39200531 PMC: 11353452. DOI: 10.3390/foods13162604.